Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Flower

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Neuropharmacology|September 3, 2011
Developing biomarkers for methamphetamine addictionJohn Mendelson, Matthew J Baggott, Keith Flower, et al.
Experimental and Clinical Psychopharmacology|October 8, 2008
Addiction to prescription opioids: characteristics of the emerging epidemic and treatment with buprenorphineJohn Mendelson, Keith Flower, Mark J Pletcher, et al.
Emergency Medicine Journal : EMJ|July 10, 2010
Validation of triage criteria for deciding which apparently inebriated persons require emergency department careKeith Flower, Anneke Post, Jeremy Sussman, et al.
Journal of Addiction Medicine|August 17, 2011
A simple, novel method for assessing medication adherence: capsule photographs taken with cellular telephonesGantt P Galloway, Jeremy R Coyle, José Enrique Guillén, et al.
Psychiatry Research|November 9, 2010
Psychiatric comorbidity in methamphetamine dependenceRuth Salo, Keith Flower, Anousheh Kielstein, et al.
Journal of Addiction Medicine|January 27, 2015
Impact of prospectively determined A118G polymorphism on treatment response to injectable naltrexone among methamphetamine-dependent patients: an open-label, pilot studyReshmi Pal, John E Mendelson, Keith Flower, et al.
The American Journal on Addictions|February 19, 2010
Methamphetamine and paranoia: the methamphetamine experience questionnaireMartin H Leamon, Keith Flower, Ruth E Salo, et al.
Psychopharmacology|December 9, 2010
Lack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: a placebo-controlled trialJohn E Mendelson, Jeremy R Coyle, Juan Carlos Lopez, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Neuropharmacology|September 3, 2011
Developing biomarkers for methamphetamine addictionJohn Mendelson, Matthew J Baggott, Keith Flower, et al.
Experimental and Clinical Psychopharmacology|October 8, 2008
Addiction to prescription opioids: characteristics of the emerging epidemic and treatment with buprenorphineJohn Mendelson, Keith Flower, Mark J Pletcher, et al.
Emergency Medicine Journal : EMJ|July 10, 2010
Validation of triage criteria for deciding which apparently inebriated persons require emergency department careKeith Flower, Anneke Post, Jeremy Sussman, et al.
Journal of Addiction Medicine|August 17, 2011
A simple, novel method for assessing medication adherence: capsule photographs taken with cellular telephonesGantt P Galloway, Jeremy R Coyle, José Enrique Guillén, et al.
Psychiatry Research|November 9, 2010
Psychiatric comorbidity in methamphetamine dependenceRuth Salo, Keith Flower, Anousheh Kielstein, et al.
Journal of Addiction Medicine|January 27, 2015
Impact of prospectively determined A118G polymorphism on treatment response to injectable naltrexone among methamphetamine-dependent patients: an open-label, pilot studyReshmi Pal, John E Mendelson, Keith Flower, et al.
The American Journal on Addictions|February 19, 2010
Methamphetamine and paranoia: the methamphetamine experience questionnaireMartin H Leamon, Keith Flower, Ruth E Salo, et al.
Psychopharmacology|December 9, 2010
Lack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: a placebo-controlled trialJohn E Mendelson, Jeremy R Coyle, Juan Carlos Lopez, et al.
Pageof 1